Rare Disease - Medika Life

Covid is commonplace. Some, are laid up with symptoms for days or weeks. A smaller group risks hospitalization or death. Should you get the booster update?

Real-World Evidence Unlocks Consumer Voice to Improve Care

Gil Bashe, Medika Life Editor - January 15, 2025

Patient Experience is the Key to Improving Drug Development and Health Care, but Are We Listening?

Treating Rare Diseases: The Challenge of Access

Ravi Santani MD - December 15, 2025

Although rare by definition, the collective impact of rare diseases is anything but insignificant. In the Asia-Pacific (APAC) region – home to over half of...

Looking for Zebras: Listening to Patients, Healing the Health System

Gil Bashe, Medika Life Editor - November 24, 2024

When the health ecosystem discounts patient experience, it fails individuals and incurs added costs. Delayed diagnoses lead to prolonged suffering, reduced quality of life, and higher medical expenses.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Why Healing Still Begins with Relationship

The Best Dating Game in Health Innovation Happens Just Off the Main Stage

Treating Rare Diseases: The Challenge of Access

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

LATEST

TRENDING

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

The Disorder That Makes Monster Faces Out of Everyone You See

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

Looking for Zebras: Listening to Patients, Healing the Health System

Real-World Evidence Unlocks Consumer Voice to Improve Care

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Treating Rare Diseases: The Challenge of Access

EDITORS CHOICE

The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It

Real-World Evidence Unlocks Consumer Voice to Improve Care

Treating Rare Diseases: The Challenge of Access

Looking for Zebras: Listening to Patients, Healing the Health System

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories